InfuSystem Holdings, Inc. (INFU)

Market Cap	189.62M +49.4%
Revenue (ttm)	143.44M +6.4%
Net Income	6.63M +182.6%
EPS	0.31 +181.8%
Shares Out	20.22M
PE Ratio	30.26
Forward PE	22.55
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,909
Open	9.62
Previous Close	9.62
Day's Range	9.31 - 9.64
52-Week Range	4.66 - 11.04
Beta	1.55
Analysts	Strong Buy
Price Target	15.00 (+59.92%)
Earnings Date	May 7, 2026

About INFU

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 473
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: INFU
• Website: https://www.infusystem.com

Financial Performance

In 2025, InfuSystem Holdings's revenue was $143.44 million, an increase of 6.36% compared to the previous year's $134.86 million. Earnings were $6.63 million, an increase of 182.60%.

Analyst Summary

According to 2 analysts, the average rating for INFU stock is "Strong Buy." The 12-month stock price target is $15.0, which is an increase of 59.92% from the latest price.

Price Target

$15.0

(59.92% upside)

Analyst Consensus: Strong Buy